Effects of the combination of fibroblast growth factor-2 and bone morphogenetic protein-2 on the proliferation and differentiation of osteoprecursor cells

Advances in Clinical and Experimental Medicine

Volumn 23, Issue 3, 2014, Pages 463-467

  Park, Jun Beom ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Bone morphogenetic protein 2; Differentiation; Fibroblast growth factor 2; Osteoblast; Proliferation

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR 2; OSTEOPONTIN;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPRECURSOR CELL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL CELL; CELL CULTURE;

3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; MICE; OSTEOBLASTS; STEM CELLS;

EID: 84905679998     PISSN: 18995276     EISSN: None     Source Type: Journal    
DOI: 10.17219/acem/37146     Document Type: Article

References (20)

1. Mansukhani A, Bellosta P, Sahni M, Basilico C: Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. I Cell Biol 2000, 149, 1297-1308. (Pubitemid 30399682)
2. Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT: Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J Biol Chem 2002, 277, 36181-36187.
3. Sobue T, Naganawa T, Xiao L, Okada Y, Tanaka Y, Ito M, Okimoto N, Nakamura T, Coffin JD, Hurley MM: Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice. J Cell Biochem 2005, 95, 83-94. (Pubitemid 41420218)
4. Kuhn LT, Ou G, Charles L, Hurley MM, Rodner CM, Gronowicz G: Fibroblast Growth Factor-2 and Bone Morphogenetic Protein-2 Have a Synergistic Stimulatory Effect on Bone Formation in Cell Cultures From Elderly Mouse and Human Bone. J Gerontol A Biol Sci Med Sci 2013.
5. Hughes-Fulford M, Li CF: The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization. J Orthop Surg Res 2011, 6, 8.
6. Park JB, Lee JY, Park HN, Seol YJ, Park YJ, Rhee SH, Lee SC, Kim KH, Kim TI, Lee YM, Ku Y, Rhyu IC, Han SB, Chung CP: Osteopromotion with synthetic oligopeptide-coated bovine bone mineral in vivo. J Periodontol 2007, 78, 157-163. (Pubitemid 46195840)
7. Maegawa N, Kawamura K, Hirose M, Yajima H, Takakura Y, Ohgushi H: Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med 2007, 1, 306-313.
8. Tanaka E, Ishino Y, Sasaki A, Hasegawa T, Watanabe M, Dalla-Bona DA, Yamano E, van Eijden TM, Tanne K: Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity. Ann Biomed Eng 2006, 34, 717-725. (Pubitemid 43824021)
9. Wang H, Zou Q, Boerman OC, Nijhuis AW, Jansen JA, Li Y, Leeuwenburgh SC: Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo. J Control Release 2012, 166, 172-181.
10. Park JB, Zhang H, Lin CY, Chung CP, Byun Y, Park YS, Yang VC: Simvastatin Maintains Osteoblastic Viability While Promoting Differentiation by Partially Regulating the Expressions of Estrogen Receptors alpha. J Surg Res 2012, 174, 278-283.
11. Park JB: The effects of dexamethasone, ascorbic acid, and beta-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression. J Surg Res 2012, 173, 99-104.
12. Park JB: Combination of simvastatin and bone morphogenetic protein-2 enhances differentiation of osteoblastic cells by regulating the expressions of phospho-Smad1/5/8. Exp Ther Med 2012, 4, 303-306.
13. Park JB: Effects of fibroblast growth factor 2 on osteoblastic proliferation and differentiation by regulating bone morphogenetic protein receptor expression. J Craniofac Surg 2011, 22, 1880-1882.
14. Park JB: Effects of doxycycline, minocycline, and tetracycline on cell proliferation, differentiation, and protein expression in osteoprecursor cells. J Craniofac Surg 2011, 22, 1839-1842.
15. Meleti Z, Shapiro IM, Adams CS: Inorganic phosphate induces apoptosis of osteoblast-like cells in culture. Bone 2000, 27, 359-366. (Pubitemid 30658118)
16. Moursi AM, Winnard PL, Winnard AV, Rubenstrunk JM, Mooney MP: Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion. Cleft Palate Craniofac J 2002, 39, 487-496. (Pubitemid 34977584)
17. Nakamura Y, Tensho K, Nakaya H, Nawata M, Okabe T, Wakitani S: Low dose fibroblast growth factor-2 (FGF-2) enhances bone morphogenetic protein-2 (BMP-2)-induced ectopic bone formation in mice. Bone 2005, 36, 399-407. (Pubitemid 40403838)
18. Park JB: Effects of low dose of estrone on the proliferation, differentiation, and mineralization of the osteoprecursor cells. Exp Ther Med 2012, 4, 681-684.
19. Huang W, Carlsen B, Rudkin G, Berry M, Ishida K, Yamaguchi DT, Miller TA: Osteopontin is a negative regulator of proliferation and differentiation in MC3T3-E1 pre-osteoblastic cells. Bone 2004, 34, 799-808. (Pubitemid 38581125)
20. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ: Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 1992, 7, 683-692.